--- a
+++ b/README.md
@@ -0,0 +1,57 @@
+<h1>TCGA Chemotherapy Response Dataset</h1>
+
+<h2>Creators</h2>
+<ul>
+  <li>Dalibor Hrg<sup>1</sup></li>
+  <li>Balthasar Huber<sup>2</sup></li>
+  <li>Lukas A. Huber<sup>1</sup></li>
+</ul>
+
+<h2>Contributors</h2>
+<p><strong>Contact persons:</strong><br>
+Dalibor Hrg<br>
+Balthasar Huber</p>
+
+<h2>Description</h2>
+<p>
+Dataset on chemotherapeutic drug responses in TCGA cancer patients, cross-referenced for a hit in the TCIA.at database, consisting of clinical (TCGA), cancer tissue gene-expression (TCGA), and tumor-immunome (TCIA) features. 
+</p>
+<p>
+The dataset includes 5 common chemotherapy agents:
+<ul>
+  <li>3 CRC agents: FOLFOX, 5FU, Oxaliplatin</li>
+  <li>2 Lung agents: Carboplatin, Cisplatin</li>
+</ul>
+</p>
+<p>
+FOLFOX, as a combinational therapy or regimen, was compiled from the timings of monotherapies given to patients and is thus a novel dataset derived from TCGA data. FOLFOX is primarily a first-line treatment, while the other drugs are not necessarily first-line treatments.
+</p>
+<p>
+Each drug dataset is available in its own CSV file.
+</p>
+
+<h2>Citation</h2>
+<p>
+Dalibor Hrg, Balthasar Huber, Lukas A. Huber. (2020). <em>TCGA Chemotherapy Response Dataset</em>. Zenodo. <a href="http://doi.org/10.5281/zenodo.3719291">http://doi.org/10.5281/zenodo.3719291</a>
+</p>
+
+<p>
+The results here are in whole or in part based upon data generated by the TCGA Research Network: <a href="https://www.cancer.gov/tcga">https://www.cancer.gov/tcga</a>
+</p>
+
+<h2>License</h2>
+<p>
+CC BY-SA 4.0 International <a href="https://creativecommons.org/licenses/by-sa/4.0">https://creativecommons.org/licenses/by-sa/4.0</a>. Authors take no liability for any use of this data.
+</p>
+
+<h2>Contributions</h2>
+<p>
+<strong>D. Hrg and B. Huber</strong>: major and equal work effort — data understanding, data science, and dataset preparation (monotherapies and FOLFOX).<br>
+<strong>L. A. Huber</strong>: contributed to the dictionary of drug names and curation/cleaning of FOLFOX entries, and clinical validation.
+</p>
+
+<h2>Contact & Maintenance</h2>
+<p>
+Email: <a href="mailto:dalibor.hrg@gmail.com">dalibor.hrg@gmail.com</a><br>
+Institutional: <a href="mailto:dalibor.hrg@i-med.ac.at">dalibor.hrg@i-med.ac.at</a>
+</p>